Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Pharmaceutics"
DOI: 10.1016/j.ijpharm.2018.10.045
Abstract: &NA; CHF5633 (Chiesi Farmaceutici, Italy) is a synthetic pulmonary surfactant currently under clinical development for the treatment of Respiratory Distress Syndrome in premature infants. The product is composed of phospholipids in liposomal organization, together with…
read more here.
Keywords:
chf5633;
fluorescence;
phospholipid components;
pulmonary surfactant ... See more keywords